Plant Versus Animal Dietary Protein and the Effect on Proteinuria

NCT04058951 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-09-20

No results posted yet for this study

Summary

The purpose of this study is to investigate if a diet high in plant protein improves kidney function in patients with kidney insufficiency and diabetes and/or hypertension and/or glomerulonephritis. The study is a non-blinded, randomized, controlled, cross-over-design with two intervention periods of each 14 days. Between the two interventions periods there is a washout period of 14 days. The participants are randomized to start with an individualized diet plan containing either high amounts of animal protein or high amounts of plant protein.

Conditions

Interventions

OTHER

High Animal Protein Diet (HAPD)

A diet containing 2,0 g protein per kilo body weight per day from primarily animal origin. To accommodate the high protein intake, the diet is supplemented with protein powder based on beef isolate.

OTHER

High Plant Protein Diet (HPPD)

A diet containing 2,0 g protein per kilo body weight per day exclusively from plant origin. To accommodate the high protein intake, the diet is supplemented with protein powder based on soy isolate.

Sponsors & Collaborators

  • Nutricia, Inc.

    collaborator INDUSTRY
  • Nordsjaellands Hospital

    collaborator OTHER
  • Jens Rikardt Andersen

    lead OTHER

Principal Investigators

  • Peter L Kristensen, Dr.med · Hilleroed Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-15
Primary Completion
2020-03-31
Completion
2020-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04058951 on ClinicalTrials.gov